Literature DB >> 15945064

Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.

Martha A Cohen1, Matthew R Skelton, Tori L Schaefer, Gary A Gudelsky, Charles V Vorhees, Michael T Williams.   

Abstract

This study determined whether developmental and adult 3,4-methylenedioxymethamphetamine (MDMA) exposures in rats have interactive effects on body temperature, learning, other behaviors, and monoamine concentrations in the hippocampus, prefrontal cortex, and striatum. Learning was assessed in the Cincinnati water maze (CWM), Morris water maze (MWM), and novel object recognition (NOR). On acquisition trials in the MWM, significant differences from developmental MDMA exposure were found on latency, cumulative distance, path length, and angle of first bearing to the goal, but the early and adult MDMA exposure group performed no worse than the developmental-only MDMA group. In the reversal trials, however, an interaction was seen: latency to the goal, cumulative distance, and angle of first bearing were increased in animals treated both developmentally and in adulthood with MDMA compared with those treated only developmentally. Other tests (elevated zero maze, CWM, NOR, and open-field activity) did not show an interaction, nor did hippocampal concentrations of serotonin or dopamine. However, several behavioral tests showed neonatal MDMA effects, including increased errors in the CWM, reduced time spent with a new object in the NOR test, and reduced locomotor activity in the open-field. By contrast, adult MDMA decreased the number of entries into open quadrants of the elevated zero maze. Litter effects were controlled by treating litter as the experimental unit and using mixed models repeated measures analyses. Correlational analyses suggested that the MWM reversal interaction involves multiple monoamine changes. The results indicate that developmental MDMA exposure can interact with adult exposure to interfere with some aspects of learning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15945064      PMCID: PMC2888299          DOI: 10.1002/syn.20166

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  49 in total

1.  Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

2.  Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress.

Authors:  Michael T Williams; LaRonda L Morford; Sandra L Wood; Stephanie L Rock; Anne E McCrea; Masao Fukumura; Tanya L Wallace; Harry W Broening; Mary S Moran; Charles V Vorhees
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

3.  Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.

Authors:  Eleanor J Bull; Peter H Hutson; Kevin C F Fone
Journal:  Neuropharmacology       Date:  2004-02       Impact factor: 5.250

4.  Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.

Authors:  James B Koprich; Er-Yun Chen; Nicholas M Kanaan; Nicholas G Campbell; Jeffrey H Kordower; Jack W Lipton
Journal:  Neurotoxicol Teratol       Date:  2003 Sep-Oct       Impact factor: 3.763

5.  Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat.

Authors:  Cindy K J Lieben; Kim van Oorsouw; Nicolaas E P Deutz; Arjan Blokland
Journal:  Behav Brain Res       Date:  2004-05-05       Impact factor: 3.332

6.  Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning.

Authors:  Jon E Sprague; Amanda S Preston; Michael Leifheit; Brian Woodside
Journal:  Physiol Behav       Date:  2003-07

Review 7.  The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors:  A Richard Green; Annis O Mechan; J Martin Elliott; Esther O'Shea; M Isabel Colado
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

Review 8.  The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Jon C Cole; Harry R Sumnall
Journal:  Neurosci Biobehav Rev       Date:  2003-05       Impact factor: 8.989

9.  Retrograde and anterograde object recognition in rats with hippocampal lesions.

Authors:  Stephane Gaskin; Annie Tremblay; Dave G Mumby
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

Review 10.  Hazard identification and predictability of children's health risk from animal data.

Authors:  LaRonda L Morford; Judith W Henck; William J Breslin; John M DeSesso
Journal:  Environ Health Perspect       Date:  2004-02       Impact factor: 9.031

View more
  24 in total

1.  (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.

Authors:  Ann M Hemmerle; Jonathan W Dickerson; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams; Kim B Seroogy
Journal:  J Comp Neurol       Date:  2012-08-01       Impact factor: 3.215

2.  3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.

Authors:  Jessica A Able; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Biol Psychiatry       Date:  2005-12-01       Impact factor: 13.382

3.  (+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.

Authors:  Matthew R Skelton; Jessica A Able; Curtis E Grace; Nicole R Herring; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Neuropharmacology       Date:  2008-07-12       Impact factor: 5.250

Review 4.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

5.  Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats.

Authors:  Matthew R Skelton; Devon L Graham; Tori L Schaefer; Curtis E Grace; Amanda A Braun; Lindsey N Burns; Robyn M Amos-Kroohs; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

6.  Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy.

Authors:  Lynn T Singer; Derek G Moore; Sarah Fulton; Julia Goodwin; John J D Turner; Meeyoung O Min; Andrew C Parrott
Journal:  Neurotoxicol Teratol       Date:  2012-03-03       Impact factor: 3.763

7.  Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

8.  Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.

Authors:  Michael T Williams; Nicole R Herring; Tori L Schaefer; Matthew R Skelton; Nicholas G Campbell; Jack W Lipton; Anne E McCrea; Charles V Vorhees
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

9.  One-year outcomes of prenatal exposure to MDMA and other recreational drugs.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Pediatrics       Date:  2012-08-20       Impact factor: 7.124

10.  Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

Authors:  Cynthia A Crawford; Michael T Williams; Jodie L Kohutek; Fiona Y Choi; Shelly T Yoshida; Sanders A McDougall; Charles V Vorhees
Journal:  Brain Res       Date:  2006-02-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.